Anixa Biosciences Inc

ANIXNASDAQ · USD
2.71USD-0.07 (-2.52%)
225

Anixa Biosciences Inc (ANIX) Wheel Strategy

No qualifying wheel strategy setups were found for ANIX in the prior session.

Read more

Running a ANIX wheel strategy lets you generate consistent premium income on Anixa Biosciences Inc while setting your own entry and exit prices on the underlying. Anixa Biosciences Inc's wheel combines cash-secured puts and covered calls into a repeatable cycle: sell puts at strikes where you'd be happy to own ANIX, and if assigned, sell calls at strikes where you'd be happy to sell. Use our scanner to find the best ANIX wheel strategy setups in real time.

The wheel works best on liquid, high-quality names with stable fundamentals and active options markets — exactly the profile many large-cap leaders fit. The mechanics are simple: sell a cash-secured put on ANIX, collect premium, and either keep the premium if it expires worthless or take assignment at a discount to current price. Once assigned, sell covered calls against the shares to keep collecting premium until they're called away. Choosing the right strikes, expirations, and IV environment is what separates a profitable ANIX wheel from a losing one.

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a preventative vaccine against ovarian cancer.

The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with MolGenie GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

The difference between a wheel that compounds and one that bleeds comes down to strike selection, IV timing, and discipline on assignment. Our scanner handles the heavy lifting: it ranks every leg of the ANIX wheel strategy by delta, premium yield, IV rank, and days to expiration, so you can deploy capital where the math works. Build your ANIX wheel strategy on data, not gut feel — and let the options wheel do what it does best: pay you to wait.

No illustrative rows to display.

As of September 24, 2026

Run the Wheel on ANIX With Confidence

Find the best ANIX wheel strategy setups across strikes and expirations, plan ahead with at-strike values, and keep your covered calls and puts on track.

Start your 14-day free trial